NCT02321930View on ClinicalTrials.gov

Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 16, 2016

Primary Completion Date

September 29, 2017

Study Completion Date

September 29, 2017

Conditions
Rheumatoid Arthritis
Interventions
DRUG

tofacitinib 5mg po bid

Trial Locations (1)

90095

UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02321930 - Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter